1-9 of 9
Sandra Lockmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Caroline Weibull, Björn E Wahlin, MD PhD, Sandra Lockmer, Gunilla Enblad, Per-Ola Andersson, MD PhD, Eva Kimby, MD PhD, Karin E. Smedby, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-140228
Published: 2020
Journal Articles

M7-FLIPI Not Valid in Follicular Lymphoma Patients with First-Line Rituximab Chemo-Free Therapy

Sandra Lockmer, MD, Weicheng Ren, PhD, Bjorn Ostenstad, MD PhD, Marianne Brodtkorb, MD PhD, Björn E Wahlin, Qiang Pan-Hammarstrom, MD PhD, Eva Kimby, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4154.
https://doi.org/10.1182/blood-2018-99-117949
Published: 2018
Journal Articles

Risk of Histological Transformation in Patients with Primary Refractory Follicular Lymphoma

Sara Alonso, MD, Martina Manni, PhD, Clementine Sarkozy, MD, Marielle Wondergem, MD, Attilio Guarini, MD, Laura Magnano, MD, Miguel Alcoceba, PhD, Martine E.D. Chamuleau, MD, Sara Galimberti, Maria Gomes da Silva, MD, Harald Holte, MD PhD, Emanuele Zucca, MD, Silvia Montoto, MD, Sandra Lockmer, MD, Igor Aurer, MD PhD, Luigi Marcheselli, MSc, Dolores Caballero, MD, Gilles Salles, MD PhD, Massimo Federico, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4145.
https://doi.org/10.1182/blood-2018-99-115956
Published: 2018
Journal Articles

The PRIMA-Prognostic Index (PI) Is Valid in Follicular Lymphoma (FL) Patients with Rituximab Chemo-Free First-Line Treatment

Eva Kimby, MD PhD, Sandra Lockmer, MD, Harald Holte, MD PhD, Björn E Wahlin, Hans Hagberg, MD, Peter De Nully Brown, Björn Östenstad, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4150.
https://doi.org/10.1182/blood-2018-99-114866
Published: 2018
Journal Articles

Long-Term Follow-up of Patients with Indolent Lymphoma after First Line Therapy with Rituximab As Single Agent or in Combination with Interferon-α2a

Sandra Lockmer, Bjorn Ostenstad, Hans Hagberg, Harald Holte, Björn Engelbrekt Wahlin, Chloe Beate Steen, Peter de Nully Brown, MD PhD, Eva Kimby
Journal: Blood
Blood (2017) 130 (Supplement 1): 2768.
https://doi.org/10.1182/blood.V130.Suppl_1.2768.2768
Published: 2017
Journal Articles

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

Chloe Beate Steen, Ellen Leich, June Helen Myklebust, PhD, Sandra Lockmer, Jillian Frances Wise, Björn Engelbrekt Wahlin, Bjørn Østenstad, Knut Liestol, Eva Kimby, Andreas Rosenwald, Erlend Bremertun Smeland, Harald Holte, Ole Christian Lingjærde, Marianne Brodtkorb
Journal: Blood
Blood (2017) 130 (Supplement 1): 1467.
https://doi.org/10.1182/blood.V130.Suppl_1.1467.1467
Published: 2017
Journal Articles

Immune Cell Dynamics in Nordic FL Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide

Sandra Lockmer, MD, Björn E Wahlin, MD PhD, Bjorn Ostenstad, MD PhD, Åsa Jeppson-Ahlberg, Birgitta Sander, MD PhD, Eva Kimby, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5338.
https://doi.org/10.1182/blood.V128.22.5338.5338
Published: 2016
Journal Articles

Sequential Immune Cell Modulation in Nordic Follicular Lymphoma Patients in the SAKK 35/10 Randomized Trial with Rituximab and Lenalidomide

Sandra Lockmer, MD PhDstud, Björn E Wahlin, MD PhD, Bjorn Ostenstad, MD PhD, Åsa Jeppson-Ahlberg, Birgitta Sander, MD PhD, Eva Kimby, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1535.
https://doi.org/10.1182/blood.V126.23.1535.1535
Published: 2015
Journal Articles

Follicular Lymphoma Survival in Sweden in the Rituximab Era

Henna Riikka Junlén, MD, Stefan Peterson, Eva Kimby, Sandra Lockmer, MD, Ola Linden, MD, Herman Nilsson-Ehle, MD PhD, Martin Erlanson, Hans Hagberg, Anders Rådlund, Oskar Hagberg, Björn E Wahlin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1758.
https://doi.org/10.1182/blood.V124.21.1758.1758
Published: 2014